Halogen-bond driven co-crystallization of potential anti-cancer compounds: a structural study

被引:22
|
作者
Aakeroey, Christer B. [1 ]
Welideniya, Dhanushi [1 ]
Desper, John [1 ]
Moore, Curtis [2 ]
机构
[1] Kansas State Univ, Dept Chem, Manhattan, KS 66506 USA
[2] UC San Diego Crystallog Lab, La Jolla, CA USA
来源
CRYSTENGCOMM | 2014年 / 16卷 / 44期
关键词
INTERMOLECULAR HYDROGEN-BOND; HEXAMETHYLENE BISACETAMIDE; DIRECTED COCRYSTALLIZATION; PHARMACEUTICAL COCRYSTALS; MOLECULAR-SOLIDS; CO-CRYSTALS; DIFFERENTIATION; FUNCTIONALITY; DESIGN; SOLUBILITY;
D O I
10.1039/c4ce01614a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The halogen-bonding ability of a series of bis-pyridine based pharmaceutically active ingredients is explored and the structural behaviour of co-crystals thereof is compared with that of their hydrogen-bonded analogues. All co-crystals are analysed using IR spectroscopy and thirteen new crystal structures comprising iodoperfluoroalkanes and bis-pyridineacetamides are presented. Binding preferences, structural patterns and correlations between molecular and crystal structures are discussed in the context of both hydrogen-and halogen bonds.
引用
收藏
页码:10203 / 10209
页数:7
相关论文
共 50 条
  • [1] Co-crystallization studies of the syn- and anti-atropisomers of triphenyl-based perfluorinated halogen bond donors with halides
    Stoesser, Julian
    Engelage, Elric
    Huber, Stefan M.
    CRYSTENGCOMM, 2022, 24 (39) : 6974 - 6979
  • [2] Structural characterization of new fluorinated mesogens obtained through halogen-bond driven self-assembly
    Kumar, Vijith
    Mulder, Dirk J.
    Cavallo, Gabriella
    Pilati, Tullio
    Terraneo, Giancarlo
    Resnati, Giuseppe
    Schenning, Albertus P. H. J.
    Metrangolo, Pierangelo
    JOURNAL OF FLUORINE CHEMISTRY, 2017, 198 : 54 - 60
  • [3] β-Lactam derivatives as potential anti-cancer compounds
    Sabine Ruf
    Gerd Neudert
    Susanne Gürtler
    Renate Grünert
    Patrick J. Bednarski
    Hans-Hartwig Otto
    Monatshefte für Chemie - Chemical Monthly, 2008, 139 : 847 - 857
  • [4] β-lactam derivatives as potential anti-cancer compounds
    Ruf, Sabine
    Neudert, Gerd
    Guertler, Susanne
    Gruenert, Renate
    Bednarski, Patrick J.
    Otto, Hans-Hartwig
    MONATSHEFTE FUR CHEMIE, 2008, 139 (07): : 847 - 857
  • [5] An Investigation of the Hydrogen-Bond Preferences and Co-crystallization Behavior of Three Didonor Compounds.
    Lemmerer, Andreas
    Adsmond, Daniel A.
    Bernstein, Joel
    CRYSTAL GROWTH & DESIGN, 2011, 11 (05) : 2011 - 2019
  • [6] Anti-galectin compounds as potential anti-cancer drugs
    Ingrassia, Laurent
    Camby, Isabelle
    Lefranc, Florence
    Mathieu, Veronique
    Nshimyumukiza, Prosper
    Darro, Francis
    Kiss, Robert
    CURRENT MEDICINAL CHEMISTRY, 2006, 13 (29) : 3513 - 3527
  • [7] Anti-Cancer Compounds Targeted to VDAC: Potential and Perspectives
    Reina, Simona
    De Pinto, Vito
    CURRENT MEDICINAL CHEMISTRY, 2017, 24 (40) : 4447 - 4469
  • [8] Determining Antibiotic and Anti-cancer Potential of Small Compounds
    Manning, Maegan
    Mowery, Patricia
    FASEB JOURNAL, 2022, 36
  • [9] ACQUISITION AND DEVELOPMENT OF NOVEL COMPOUNDS AS POTENTIAL ANTI-CANCER AGENTS
    NARAYANAN, VL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1979, (SEP): : 9 - 9
  • [10] Gene expression driven discovery of novel anti-cancer compounds.
    Cholody, WM
    Petukhova, V
    Ohler, N
    O'Brien, SA
    Strovel, J
    Tatunchak, T
    Majolagbe, A
    Pikul, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U47 - U47